Medications

Botox developer rues missing out on billions

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Obstetrics & gynaecology

Do hormonal contraceptives impact glaucoma risk?

Women who currently use hormonal contraceptives face more than a 2-fold higher risk of developing glaucoma, according to an analysis of electronic medical records for women aged 15-45 years from 2008 to 2018. The British ...

Health

CMS: hospital charges for common procedures up

(HealthDay)—The prices hospitals charge patients for a number of common procedures rose more than 10 percent between 2011 and 2013, more than twice the rate of inflation, according to data released by the federal government ...

Ophthalmology

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, Director ...

Health

Eyelash extension adhesives may cause bad reactions

(HealthDay)—For those who aren't born with long, fluttery eyelashes, cosmetic extensions can help achieve that often sought-after look. But eye experts warn that the adhesives used to apply these eyelash extensions can ...

Health

Investigation sheds doubt on a 'shaken-baby' murder conviction

(Medical Xpress)—Based on developments in science and interviews with numerous medical experts, an in-depth investigation by Northwestern University's Medill Innocence Project raises significant questions about the murder ...

page 4 from 6